A Phase 1 Study of OTS-412 (Recombinant Oncolytic Vaccinia Virus) in Treatment-refractory Solid Tumor Patients (South Korea)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This clinical trial aims to determine whether the administration of the investigational drug OTS-412, OTS-412 in combination with hydroxyurea or hydroxyurea/atezolizumab is safe and effective for patients with various types of cancer.
Epistemonikos ID: 4a2ecf565f50d6c2576ad30e41c97322cc2acd12
First added on: Sep 25, 2025